GALT · Galectin Therapeutics Inc
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Positioning
Aug 21, 2026 · 5 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 32 | 10 | — | — | $1.00 | $0.10 | -0.185 | 404.6% | 3 | 15 | |
| 2.3k | 13 | 283.5% | 0.179 | $0.03 | $2.91 | -0.946 | 179.8% | 3 | 594 | |
| 484 | 90 | 428.3% | 0.106 | $0.05 | — | -0.93 | 375.8% | — | 0 | |
| 6 | 5 | — | — | $0.05 | — | — | — | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Jul 24, 2026–Aug 14, 2026; 2 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.